ConductScience.org, home

Paper38947228

Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report.

Leger KJ and 14 others. Front Cardiovasc Med, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report. Papers, record 38947228. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38947228

Download JSON
Disease
acute myeloid leukemia587 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report.
PubMed
Journal
Front Cardiovasc Med
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.99, provisional
iCite
Revised in PubMed
2025-07-21
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leger KJKasey J
2Absalon MJMichael J
3Demissei BGBiniyam G
4Smith AMAmanda M
5Gerbing RBRobert B
6Alonzo TATodd A
7Narayan HKHari K
8Hirsch BABetsy A
9Pollard JAJessica A
10Razzouk BIBassem I
11Getz KDKelly D
12Aplenc RRichard
13Kolb EAE Anders
14Ky BBonnie
15Cooper TMTodd M

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K24 HL167127NHLBI NIH HHSUnited StatesK24HL167127PubMed and NIHNIH RePORTER
K23 HL163456NHLBI NIH HHSUnited StatesK23HL163456PubMedNIH RePORTER
K01 HL143153NHLBI NIH HHSUnited StatesK01HL143153PubMed and NIHNIH RePORTER
U10 CA180899NCI NIH HHSUnited StatesU10CA180899PubMed and NIHNIH RePORTER
U10 CA180886NCI NIH HHSUnited StatesU10CA180886PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04293562A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121298750Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United Kingdom.Pediatr Blood Cancer2011https://conductscience.org/library/papers/21298750PubMed
217054231Different anthracycline derivates for reducing cardiotoxicity in cancer patients.Cochrane Database Syst Rev2006https://conductscience.org/library/papers/17054231PubMed
316375591N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability.Clin Chem Lab Med2006https://conductscience.org/library/papers/16375591PubMed
43411343Doxorubicin clearance in the obese.J Clin Oncol1988https://conductscience.org/library/papers/3411343PubMed
535277733Age-Dependent Reference Values for hs-Troponin T and NT-proBNP and Determining Factors in a Cohort of Healthy Children (The LIFE Child Study).Pediatr Cardiol2022https://conductscience.org/library/papers/35277733PubMed
632466789Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure.BMC Pharmacol Toxicol2020https://conductscience.org/library/papers/32466789PubMed
78993985
Reproducibility of left ventricular size, shape and mass with echocardiography, magnetic resonance imaging and radionuclide angiography in patients with anterior wall infarction. A plea for core laboratories.
Int J Card Imaging1996https://conductscience.org/library/papers/8993985PubMed
837397086Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer.JACC CardioOncol2023https://conductscience.org/library/papers/37397086PubMed
912413441
Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction.
Eur J Echocardiogr2002https://conductscience.org/library/papers/12413441PubMed
1030379624Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group.J Clin Oncol2019https://conductscience.org/library/papers/30379624PubMed
1127206819
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Eur Heart J2016https://conductscience.org/library/papers/27206819PubMed
1231351792Challenges With Left Ventricular Functional Parameters: The Pediatric Heart Network Normal Echocardiogram Database.J Am Soc Echocardiogr2019https://conductscience.org/library/papers/31351792PubMed
1327708836Pathophysiology of sepsis-induced myocardial dysfunction.Mil Med Res2016https://conductscience.org/library/papers/27708836PubMed
1430024784CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia.J Clin Oncol2018https://conductscience.org/library/papers/30024784PubMed
1529966479Congestive heart failure among children with acute leukemia: a population-based matched cohort study.Leuk Lymphoma2019https://conductscience.org/library/papers/29966479PubMed
1623319696Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group.J Clin Oncol2013https://conductscience.org/library/papers/23319696PubMed
1727085442Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.JACC Cardiovasc Imaging2016https://conductscience.org/library/papers/27085442PubMed
1823697708Fat and lean BMI reference curves in children and adolescents and their utility in identifying excess adiposity compared with BMI and percentage body fat.Am J Clin Nutr2013https://conductscience.org/library/papers/23697708PubMed
1925616572Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. program.Haematologica2015https://conductscience.org/library/papers/25616572PubMed
207760889Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.N Engl J Med1995https://conductscience.org/library/papers/7760889PubMed

See all 27 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41594244Pediatric Cardio-Oncology: From Gap in Evidence to Future Perspectives.Diagnostics (Basel)2026https://conductscience.org/library/papers/41594244PubMed
41118594CPX-351 in Down syndrome-associated myeloid leukemia: results and prognostic factors from the phase 3 ML-DS 2018 trial.Blood2026https://conductscience.org/library/papers/41118594PubMed
41096539A Novel Approach to Prognostic Factors and Risk Stratification in Pediatric AML: Case Report and Literature Review.Int J Mol Sci2025https://conductscience.org/library/papers/41096539PubMed
40815417Safety of liposomal daunorubicin-cytarabine (CPX-351) in secondary AML: Japanese phase 1/2 study and global phase 3 study.Int J Hematol2025https://conductscience.org/library/papers/40815417PubMed
40778417Precision oncology to overcome resistance in R/R AML in children and adults requires combinations of cytotoxic, targeted, and immunological treatments.J Intern Med2025https://conductscience.org/library/papers/40778417PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TNNT27139PubTator's text mininghttps://conductscience.org/library/genes/7139

Source NCBI Gene

Download CSV of genes

Drugs9

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
DEXRAZOXANE HYDROCHLORIDECHEMBL1200778Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1200778ChEMBL
GEMTUZUMAB OZOGAMICINCHEMBL1201506Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1201506ChEMBL
MITOXANTRONE HYDROCHLORIDECHEMBL1417019Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1417019ChEMBL
DAUNORUBICIN HYDROCHLORIDECHEMBL1563Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1563ChEMBL
ASPARAGINASE ERWINIA CHRYSANTHEMICHEMBL1863514Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1863514ChEMBL
GILTERITINIBCHEMBL3301622Derived from the trial1https://conductscience.org/library/drugs/CHEMBL3301622ChEMBL
METHOTREXATECHEMBL34259Derived from the trial1https://conductscience.org/library/drugs/CHEMBL34259ChEMBL
ETOPOSIDECHEMBL44657Derived from the trial1https://conductscience.org/library/drugs/CHEMBL44657ChEMBL
CYTARABINECHEMBL803Derived from the trial1https://conductscience.org/library/drugs/CHEMBL803ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38947228

GET https://conductscience.org/api/papers/v1/38947228/references?page=2